These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 31629395)

  • 21. Coexpression of tyrosine hydroxylase, GTP cyclohydrolase I, aromatic amino acid decarboxylase, and vesicular monoamine transporter 2 from a helper virus-free herpes simplex virus type 1 vector supports high-level, long-term biochemical and behavioral correction of a rat model of Parkinson's disease.
    Sun M; Kong L; Wang X; Holmes C; Gao Q; Zhang GR; Pfeilschifter J; Goldstein DS; Geller AI
    Hum Gene Ther; 2004 Dec; 15(12):1177-96. PubMed ID: 15684695
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Localization and functional significance of striatal neurons immunoreactive to aromatic L-amino acid decarboxylase or tyrosine hydroxylase in rat Parkinsonian models.
    Lopez-Real A; Rodriguez-Pallares J; Guerra MJ; Labandeira-Garcia JL
    Brain Res; 2003 Apr; 969(1-2):135-46. PubMed ID: 12676374
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dopamine but not l-dopa stimulates neural glutathione metabolism. Potential implications for Parkinson's and other dopamine deficiency states.
    Allen GF; Ullah Y; Hargreaves IP; Land JM; Heales SJ
    Neurochem Int; 2013 Apr; 62(5):684-94. PubMed ID: 23261515
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antisense oligonucleotides modulate dopa decarboxylase function in aromatic l-amino acid decarboxylase deficiency.
    Tsai CR; Lee HF; Chi CS; Yang MT; Hsu CC
    Hum Mutat; 2018 Dec; 39(12):2072-2082. PubMed ID: 30260058
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comprehensive proteomics of CSF, plasma, and urine identify DDC and other biomarkers of early Parkinson's disease.
    Rutledge J; Lehallier B; Zarifkar P; Losada PM; Shahid-Besanti M; Western D; Gorijala P; Ryman S; Yutsis M; Deutsch GK; Mormino E; Trelle A; Wagner AD; Kerchner GA; Tian L; Cruchaga C; Henderson VW; Montine TJ; Borghammer P; Wyss-Coray T; Poston KL
    Acta Neuropathol; 2024 Mar; 147(1):52. PubMed ID: 38467937
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Alpha-synuclein inhibits aromatic amino acid decarboxylase activity in dopaminergic cells.
    Tehranian R; Montoya SE; Van Laar AD; Hastings TG; Perez RG
    J Neurochem; 2006 Nov; 99(4):1188-96. PubMed ID: 16981894
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A rostrocaudal gradient for aromatic acid decarboxylase in the human striatum.
    Garnett ES; Lang AE; Chirakal R; Firnau G; Nahmias C
    Can J Neurol Sci; 1987 Aug; 14(3 Suppl):444-7. PubMed ID: 3119181
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Functional effect of adeno-associated virus mediated gene transfer of aromatic L-amino acid decarboxylase into the striatum of 6-OHDA-lesioned rats.
    Sánchez-Pernaute R; Harvey-White J; Cunningham J; Bankiewicz KS
    Mol Ther; 2001 Oct; 4(4):324-30. PubMed ID: 11592835
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A probe for intracerebral aromatic amino-acid decarboxylase activity: distribution and kinetics of [18F]6-fluoro-L-m-tyrosine in the human brain.
    Nahmias C; Wahl L; Chirakal R; Firnau G; Garnett ES
    Mov Disord; 1995 May; 10(3):298-304. PubMed ID: 7651447
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dual effects of L-3,4-dihydroxyphenylalanine on aromatic L-amino acid decarboxylase, dopamine release and motor stimulation in the reserpine-treated rat: evidence that behaviour is dopamine independent.
    Fisher A; Biggs CS; Eradiri O; Starr MS
    Neuroscience; 2000; 95(1):97-111. PubMed ID: 10619466
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neuroprotective and neurotoxic roles of levodopa (L-DOPA) in neurodegenerative disorders relating to Parkinson's disease.
    Kostrzewa RM; Kostrzewa JP; Brus R
    Amino Acids; 2002; 23(1-3):57-63. PubMed ID: 12373519
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Depletion of AADC activity in caudate nucleus and putamen of Parkinson's disease patients; implications for ongoing AAV2-AADC gene therapy trial.
    Ciesielska A; Samaranch L; San Sebastian W; Dickson DW; Goldman S; Forsayeth J; Bankiewicz KS
    PLoS One; 2017; 12(2):e0169965. PubMed ID: 28166239
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transplantation of autologous sympathetic neurons as a potential strategy to restore metabolic functions of the damaged nigrostriatal dopamine nerve terminals in Parkinson's disease.
    Nakao N; Shintani-Mizushima A; Kakishita K; Itakura T
    Brain Res Rev; 2006 Sep; 52(2):244-56. PubMed ID: 16644019
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Structural and functional analogies and differences between histidine decarboxylase and aromatic l-amino acid decarboxylase molecular networks: Biomedical implications.
    Sanchez-Jiménez F; Pino-Ángeles A; Rodríguez-López R; Morales M; Urdiales JL
    Pharmacol Res; 2016 Dec; 114():90-102. PubMed ID: 27769832
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Carbidopa-based modulation of the functional effect of the AAV2-hAADC gene therapy in 6-OHDA lesioned rats.
    Ciesielska A; Sharma N; Beyer J; Forsayeth J; Bankiewicz K
    PLoS One; 2015; 10(4):e0122708. PubMed ID: 25860990
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Crystal structure and substrate specificity of Drosophila 3,4-dihydroxyphenylalanine decarboxylase.
    Han Q; Ding H; Robinson H; Christensen BM; Li J
    PLoS One; 2010 Jan; 5(1):e8826. PubMed ID: 20098687
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Use of radiolabeled monofluoromethyl-Dopa to define the subunit structure of human L-Dopa decarboxylase.
    Maneckjee R; Baylin SB
    Biochemistry; 1983 Dec; 22(26):6058-63. PubMed ID: 6661425
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Quantification of mRNA of tyrosine hydroxylase and aromatic L-amino acid decarboxylase in the substantia nigra in Parkinson's disease and schizophrenia.
    Ichinose H; Ohye T; Fujita K; Pantucek F; Lange K; Riederer P; Nagatsu T
    J Neural Transm Park Dis Dement Sect; 1994; 8(1-2):149-58. PubMed ID: 7893377
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Opposite effects of glutamate antagonists and antiparkinsonian drugs on the activities of DOPA decarboxylase and 5-HTP decarboxylase in the rat brain.
    Fisher A; Starr MS
    Brain Res; 2000 Jun; 868(2):268-74. PubMed ID: 10854579
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Aromatic L-amino acid decarboxylase in rat corpus striatum: implications for action of L-dopa in parkinsonism.
    Melamed E; Hefti F; Pettibone DJ; Liebman J; Wurtman RJ
    Neurology; 1981 Jun; 31(6):651-5. PubMed ID: 7195482
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.